KVUE (Kenvue Inc.) Earnings per share growth rate in current year
The percentage deviation of EPS from last year's level demonstrates moderate volatility, with the value recorded at 8.40. This trend is constrained by logistics disruptions in raw material supplies and inflationary pressure. However, the resilience of Kenvue Inc. (KVUE) relies on the predictable cash flow of this independent consumer health behemoth and long-term customer loyalty to legendary brands, despite residual legal risks regarding talc.
Analytical breakdowns and data insights for company Kenvue Corp (KVUE)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
- net income and valuation multiples indicators:
KVUE - Net Income|Expected Net Income Kenvue Inc.|KVUE - P/E Multiple|Market Cap to Projected Earnings kenvue.com|KVUE - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Kenvue|KVUE - Operating profit EBITDA|Net earnings per share for the last 12 months Kenvue|KVUE - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months kenvue.com|KVUE - Earnings per share growth in current year|Earnings growth forecast for next year Kenvue Inc.
- revenue and sales proceeds data:
Summary company analysis:Kenvue Inc., KVUE
Kenvue Inc. maintains stability through high capacity utilization and systemic line automation, which is reflected in the annual EPS growth trend. This indicator measures the percentage increase in net profit per share relative to the previous year, allowing investors to assess business scaling efficiency and determine the fair value of assets through the lens of real returns.
Key competitors
Earnings per share growth rate in current year Haleon Corp (HLN)|VRNA (Verona Pharma PLC) - Earnings growth in current year|Earnings per share growth rate in current year jyongbio.com MENS|Earnings per share growth in current year Ligand (LGND)|AMRX (Amneal) - Earnings per share increase in current year|Earnings per share growth in current year Perrigo PRGO|Earnings growth in current year Alvotech Biopharmaceuticals ALVO|liquidia.com - Earnings growth in current year|GLPG - Earnings growth in current year|ANIP: Earnings growth in current year|Earnings per share growth this year MNKD|AMPH (Amphastar) - Earnings growth in current year|Pacira Corp (PCRX) - Expected net earnings per share growth this year|Earnings per share growth in current year ARS Pharma (SPRY)|Earnings growth in current year Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Net earnings per share growth this year|Earnings per share increase in current year SCPH|Tectonic Therapeutic Inc. - Earnings growth in current year|Earnings per share trend in current year TNXP|SXTC (China SXT Pharmaceuticals) - Net earnings per share growth this year|Eupraxia Pharmaceuticals (EPRX) - Earnings growth in current year|Earnings per share growth in current year BioHarvest Sciences, Inc.|EXOZ: Earnings per share increase in current year|Earnings growth in current year ORMP|ENTX - Earnings per share growth rate in current year|Earnings per share growth in current year MindWalk Holdings, Inc. HYFT|Earnings growth in current year abvcpharma.com ABVC|CPIX - Earnings per share growth in current year|Earnings per share trend in current year QNTM|FGEN (FibroGen Corporation) - Net earnings per share growth this year|Net earnings per share growth this year Telomir Pharma|Net earnings per share growth this year RANI|Earnings per share growth rate in current year synergychc.com SNYR|Earnings per share growth in current year Rallybio Corp (RLYB)|LEXX - Earnings per share growth rate in current year|Pulmatrix Inc - Net earnings per share growth this year|Earnings per share increase in current year PTHL|Aptorum Group Ltd - Earnings growth in current year|Expected net earnings per share growth this year Lyra Therapeutics LYRA|IBO: Earnings growth in current year|TNFA (TNF Pharma) - Earnings per share growth in current year|Earnings per share growth in current year cbdmd.com|Earnings per share growth this year PRFX (PainReform Corp)|Earnings growth in current year CYTO|Net earnings per share growth this year Lipella Pharmaceuticals LIPO|Earnings per share growth in current year OptiNose OPTN|Pieris Pharmaceuticals Inc - Earnings per share growth in current year|Procaps Group Corp - Earnings growth in current year|Expected net earnings per share growth this year Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN (SLRN) - Earnings growth in current year|Earnings per share growth in current year TFF Pharmaceuticals
